PTC Therapeutics, Inc. (PTCT)
Health Care ยท Pharmaceutical Preparations
PTC Therapeutics, Inc. (PTCT) is listed on Nasdaq, where its shares have traded since June 20, 2013. SentiSense covers PTC Therapeutics, Inc. in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations. Matthew B. Klein is its chief executive officer. The company reports 991 employees, and its corporate website is www.ptcbio.com.
About PTC Therapeutics, Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 372 institutions reported holding PTCT, with 100.3 million shares worth $8.2 billion in aggregate. The largest reported holders were BlackRock, Vanguard and Rtw Investments. Of the 5 largest reported holders, 4 added shares and 1 held its position unchanged during the quarter.
More on PTCT
- PTCT sentiment: whether news and social coverage of PTC Therapeutics, Inc. leans bullish or bearish, and the stories driving it.
- PTCT ownership: all 372 reporting institutions, plus insider and congressional trades.
- PTCT financials: revenue, net income, operating margin and free cash flow by quarter and year.
SentiSense also tracks daily options readings for PTC Therapeutics, Inc.: IV rank, put/call percentile, 25-delta skew and open-interest walls.
Frequently asked questions
What does PTC Therapeutics, Inc. do?
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders.
What sector is PTCT in?
SentiSense classifies PTC Therapeutics, Inc. in the Health Care sector, and its Standard Industrial Classification is Pharmaceutical Preparations.
Where does PTCT stock trade?
PTC Therapeutics, Inc. (PTCT) is listed on Nasdaq, where its shares have traded since June 20, 2013.
Who is the CEO of PTC Therapeutics, Inc.?
Matthew B. Klein is the chief executive officer of PTC Therapeutics, Inc..